BlackRock
AZN icon

BlackRock’s AstraZeneca AZN Stock Holding History

BlackRock’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-419,000
Closed -$56.8M – 5281
2024
Q1 		$56.8M Buy
+419,000
New +$55.5M ﹤0.01% 2367
2023
Q1 		– Sell
-171,000
Closed -$23.2M – 5576
2022
Q4 		$23.2M Buy
+171,000
New +$21.4M ﹤0.01% 2945

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock's AZN Position: Q2 2026 in Review

BlackRock reduced its AstraZeneca (AZN) stake by 2.8% in Q2 2026, selling an estimated $11.8M and leaving 2,169,622 shares worth $411M. The position accounts for 0.01% of the portfolio, ranked #1354.

BlackRock first reported a position in AZN in Q2 2014 and has held it in 47 quarters since. The position peaked at $821M in Q4 2022. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • BlackRock held 2,169,622 shares of AstraZeneca worth $411M as of Q2 2026.
  • BlackRock sold 62,567 AstraZeneca shares in Q2 2026, an estimated $11.8M.
  • AstraZeneca made up 0.01% of BlackRock's portfolio in Q2 2026, its #1354 holding.
  • BlackRock first reported a position in AstraZeneca in Q2 2014 and has held it in 47 quarters since.
  • BlackRock's AstraZeneca position peaked at $821M in Q4 2022.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.